BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7968458)

  • 1. Mutagenesis of the Clostridium difficile toxin B gene and effect on cytotoxic activity.
    Barroso LA; Moncrief JS; Lyerly DM; Wilkins TD
    Microb Pathog; 1994 Apr; 16(4):297-303. PubMed ID: 7968458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and expression of Clostridium difficile toxin A gene (tcdA) by PCR amplification and use of an expression vector.
    Ackermann G; Löffler B; Tang-Feldman YJ; Cohen SH; Silva J; Rodloff AC
    Mol Cell Probes; 2004 Aug; 18(4):271-4. PubMed ID: 15271388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enzymatic domain of Clostridium difficile toxin A is located within its N-terminal region.
    Faust C; Ye B; Song KP
    Biochem Biophys Res Commun; 1998 Oct; 251(1):100-5. PubMed ID: 9790914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HlyC, the internal protein acyltransferase that activates hemolysin toxin: role of conserved histidine, serine, and cysteine residues in enzymatic activity as probed by chemical modification and site-directed mutagenesis.
    Trent MS; Worsham LM; Ernst-Fonberg ML
    Biochemistry; 1999 Mar; 38(11):3433-9. PubMed ID: 10079090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [PCR cloning of 3'-terminal repeat fragments of Clostridium difficile toxin A and toxin B gene].
    Yang XQ; Jiang B; Sun Y; Wang JD
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):791-3. PubMed ID: 12297432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B.
    Genisyuerek S; Papatheodorou P; Guttenberg G; Schubert R; Benz R; Aktories K
    Mol Microbiol; 2011 Mar; 79(6):1643-54. PubMed ID: 21231971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface association.
    Demarest SJ; Salbato J; Elia M; Zhong J; Morrow T; Holland T; Kline K; Woodnutt G; Kimmel BE; Hansen G
    J Mol Biol; 2005 Mar; 346(5):1197-206. PubMed ID: 15713474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.
    Persson S; Torpdahl M; Olsen KE
    Clin Microbiol Infect; 2008 Nov; 14(11):1057-64. PubMed ID: 19040478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clostridium difficile strains not producing Toxin A, but producing Toxin B [toxA(-)tox B(+)]--etiologic agent of antibiotic associated diarrhoea (AAD) in Poland].
    Pituch H; Obuch-Woszczatyński P; Meisel-Mikołajczyk F; Łuczak M
    Med Dosw Mikrobiol; 2002; 54(1):45-53. PubMed ID: 12185683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the pathogenicity locus in Clostridium difficile strains.
    Cohen SH; Tang YJ; Silva J
    J Infect Dis; 2000 Feb; 181(2):659-63. PubMed ID: 10669352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterisation of toxin A-negative, toxin B-positive Clostridium difficile in Dublin, Ireland.
    Drudy D; Harnedy N; Fanning S; O'Mahony R; Kyne L
    Clin Microbiol Infect; 2007 Mar; 13(3):298-304. PubMed ID: 17391385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repression of Clostridium difficile toxin gene expression by CodY.
    Dineen SS; Villapakkam AC; Nordman JT; Sonenshein AL
    Mol Microbiol; 2007 Oct; 66(1):206-19. PubMed ID: 17725558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of wild type with recombinant Clostridium difficile toxin A.
    Gerhard R; Burger S; Tatge H; Genth H; Just I; Hofmann F
    Microb Pathog; 2005; 38(2-3):77-83. PubMed ID: 15748809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive regulation of Clostridium difficile toxins.
    Moncrief JS; Barroso LA; Wilkins TD
    Infect Immun; 1997 Mar; 65(3):1105-8. PubMed ID: 9038324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative sequence analysis of the Clostridium difficile toxins A and B.
    von Eichel-Streiber C; Laufenberg-Feldmann R; Sartingen S; Schulze J; Sauerborn M
    Mol Gen Genet; 1992 May; 233(1-2):260-8. PubMed ID: 1603068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxins A and B of Clostridium difficile.
    Wolfhagen MJ; Torensma R; Fluit AC; Verhoef J
    FEMS Microbiol Rev; 1994 Jan; 13(1):59-64. PubMed ID: 8117467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Closing in on the toxic domain through analysis of a variant Clostridium difficile cytotoxin B.
    von Eichel-Streiber C; Meyer zu Heringdorf D; Habermann E; Sartingen S
    Mol Microbiol; 1995 Jul; 17(2):313-21. PubMed ID: 7494480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of Clostridium difficile toxins.
    Moncrief JS; Wilkins TD
    Curr Top Microbiol Immunol; 2000; 250():35-54. PubMed ID: 10981356
    [No Abstract]   [Full Text] [Related]  

  • 19. Molecular characterization of the Clostridium difficile toxin A gene.
    Dove CH; Wang SZ; Price SB; Phelps CJ; Lyerly DM; Wilkins TD; Johnson JL
    Infect Immun; 1990 Feb; 58(2):480-8. PubMed ID: 2105276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Oligosaccharides in Human Milk Bound onto the Toxin A Carbohydrate Binding Site of Clostridium difficile.
    Nguyen TT; Kim JW; Park JS; Hwang KH; Jang TS; Kim CH; Kim D
    J Microbiol Biotechnol; 2016 Apr; 26(4):659-65. PubMed ID: 26718473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.